Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial - Raskob, G E; van Es, N; Segers, A (Lancet Haematol, 2016)
et al.